{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:53:38Z","timestamp":1793069618209,"version":"4.5.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.4065\/mcp.2010.0414","type":"journal-article","created":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T19:14:15Z","timestamp":1291230855000},"page":"1111-1120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":123,"title":["Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer"],"prefix":"10.4065","volume":"85","author":[{"given":"Sandhya","family":"Pruthi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobbie S.","family":"Gostout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noralane M.","family":"Lindor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"38","key":"10.4065\/mcp.2010.0414_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jncimonographs\/lgn001","article-title":"Concise handbook of familial cancer susceptibility syndromes: second edition","volume":"2008","author":"Lindor","year":"2008","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"4","key":"10.4065\/mcp.2010.0414_bib2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.4065\/mcp.2010.0414_bib3","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","article-title":"Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer","volume":"68","author":"Risch","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.4065\/mcp.2010.0414_bib4","author":"ACOG"},{"issue":"9","key":"10.4065\/mcp.2010.0414_bib5","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrc1431","article-title":"BRCA1 and BRCA2: 1994 and beyond","volume":"4","author":"Narod","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.4065\/mcp.2010.0414_bib6","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.suc.2008.04.007","article-title":"Management of women who have a genetic predisposition for breast cancer","volume":"88","author":"Jatoi","year":"2008","journal-title":"Surg Clin North Am"},{"issue":"8","key":"10.4065\/mcp.2010.0414_bib7","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/jnci\/djj132","article-title":"Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1\/2 Carrier Cohort Study (IBCCS)","volume":"98","author":"Andrieu","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.4065\/mcp.2010.0414_bib8","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies [published correction appears in Am J Hum Genet. 2003;73(3):709]","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.4065\/mcp.2010.0414_bib9","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1158\/1055-9965.EPI-08-0546","article-title":"Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the International BRCA1\/2 Carrier Cohort Study","volume":"18","author":"Antoniou","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"10.4065\/mcp.2010.0414_bib10","doi-asserted-by":"crossref","first-page":"R833","DOI":"10.1186\/bcr1293","article-title":"Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers","volume":"7","author":"Kotsopoulos","year":"2005","journal-title":"Breast Cancer Res"},{"issue":"14","key":"10.4065\/mcp.2010.0414_bib11","first-page":"5420","article-title":"Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history","volume":"61","author":"Rebbeck","year":"2001","journal-title":"Cancer Res"},{"issue":"9","key":"10.4065\/mcp.2010.0414_bib12","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/bjc.1998.251","article-title":"The effects of interaction between familial and reproductive factors on breast cancer risk: a combined analysis of seven case-control studies","volume":"77","author":"Andrieu","year":"1998","journal-title":"Br J Cancer"},{"issue":"1","key":"10.4065\/mcp.2010.0414_bib13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1470-2045(06)70983-4","article-title":"Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study","volume":"8","author":"McLaughlin","year":"2007","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.4065\/mcp.2010.0414_bib14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1023\/A:1024932427503","article-title":"Reproductive factors and ovarian cancer risk in Jewish BRCA1 and BRCA2 mutation carriers (United States)","volume":"14","author":"Modugno","year":"2003","journal-title":"Cancer Causes Control"},{"issue":"23","key":"10.4065\/mcp.2010.0414_bib15","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1200\/JCO.2009.27.5933","article-title":"Is mammographic breast density a breast cancer risk factor in women with BRCA mutations?","volume":"28","author":"Passaperuma","year":"2010","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.4065\/mcp.2010.0414_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2003.10.005","article-title":"Epidemiology of breast cancer among BRCA mutation carriers: an overview","volume":"205","author":"Nkondjock","year":"2004","journal-title":"Cancer Lett"},{"issue":"5645","key":"10.4065\/mcp.2010.0414_bib17","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","article-title":"Breast and ovarian cancer risks due to inherited mutations in BRC1 and BRCA2","volume":"302","author":"King","year":"2003","journal-title":"Science"},{"issue":"3","key":"10.4065\/mcp.2010.0414_bib18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10549-006-9161-8","article-title":"Diet, lifestyle and BRCA-related breast cancer risk among French-Canadians","volume":"98","author":"Nkondjock","year":"2006","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"10.4065\/mcp.2010.0414_bib19","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","article-title":"Meta-analysis of BRCA1 and BRCA2 penetrance","volume":"25","author":"Chen","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.4065\/mcp.2010.0414_bib20","author":"National Cancer Institute"},{"issue":"2","key":"10.4065\/mcp.2010.0414_bib21","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMcp071286","article-title":"Clinical practice: management of an inherited predisposition to breast cancer","volume":"357","author":"Robson","year":"2007","journal-title":"N Engl J Med"},{"issue":"18","key":"10.4065\/mcp.2010.0414_bib22","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/jnci\/94.18.1358","article-title":"Cancer incidence in BRCA1 mutation carriers","volume":"94","author":"Thompson","year":"2002","journal-title":"J Natl Cancer Inst"},{"issue":"24","key":"10.4065\/mcp.2010.0414_bib23","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","article-title":"Projecting individualized probabilities of developing breast cancer for white females who are being examined annually","volume":"81","author":"Gail","year":"1989","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.4065\/mcp.2010.0414_bib24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1524-4741.2002.08005.x","article-title":"Limitations of the Gail model in the specialized breast cancer risk assessment clinic","volume":"8","author":"Euhus","year":"2002","journal-title":"Breast J"},{"issue":"2","key":"10.4065\/mcp.2010.0414_bib25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF00666424","article-title":"The calculation of breast cancer risk for women with a first degree family history of ovarian cancer","volume":"28","author":"Claus","year":"1993","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"10.4065\/mcp.2010.0414_bib26","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/sim.1668","article-title":"A breast cancer prediction model incorporating familial and personal risk factors [published correction appears in Stat Med. 2005;24(1):156]","volume":"23","author":"Tyrer","year":"2004","journal-title":"Stat Med"},{"key":"10.4065\/mcp.2010.0414_bib27","author":"Cuzick"},{"issue":"3","key":"10.4065\/mcp.2010.0414_bib28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/jnci\/89.3.227","article-title":"Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history","volume":"89","author":"Berry","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.4065\/mcp.2010.0414_bib29","series-title":"Requesting CancerGene","author":"UT Southwestern Medical Center","year":"2010"},{"issue":"5","key":"10.4065\/mcp.2010.0414_bib30","first-page":"355","article-title":"Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement [published correction appears in Ann Intern Med. 2005;143(7):547]","volume":"143","author":"US Preventive Services Task Force","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.4065\/mcp.2010.0414_bib31","doi-asserted-by":"crossref","first-page":"a2079","DOI":"10.1136\/bmj.a2079","article-title":"Recruitment to multicentre trials\u2013lessons from UKCTOCS: descriptive study [published correction appears in BMJ. 2008;337:a2976]","volume":"337","author":"Menon","year":"2008","journal-title":"BMJ"},{"issue":"11","key":"10.4065\/mcp.2010.0414_bib32","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1136\/jmg.40.11.807","article-title":"Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme","volume":"40","author":"Amir","year":"2003","journal-title":"J Med Genet"},{"key":"10.4065\/mcp.2010.0414_bib33","series-title":"National Society of Genetic Counselors. (nsgc) Web site","year":"1995"},{"key":"10.4065\/mcp.2010.0414_bib34","unstructured":"Genetic Information Nondiscrimination Act of 2008. Pub L 110-233, 122 Stat. 881 (May 21, 2008)."},{"issue":"2","key":"10.4065\/mcp.2010.0414_bib35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3322\/canjclin.57.2.75","article-title":"American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography [published correction appears in CA Cancer J Clin. 2007;57(3):185]","volume":"57","author":"Saslow","year":"2007","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"10.4065\/mcp.2010.0414_bib36","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1089\/jwh.2008.1076","article-title":"The attitudes of women with BRCA1 and BRCA2 mutations toward clinical breast examinations and breast self-examinations","volume":"18","author":"Spiegel","year":"2009","journal-title":"J Womens Health (Larchmt)"},{"issue":"17","key":"10.4065\/mcp.2010.0414_bib37","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa052911","article-title":"Diagnostic performance of digital versus film mammography for breast-cancer screening [published correction appears in N Engl J Med. 2006;355(17):1840]","volume":"353","author":"Pisano","year":"2005","journal-title":"N Engl J Med"},{"issue":"5, part 1","key":"10.4065\/mcp.2010.0414_bib38","doi-asserted-by":"crossref","first-page":"347","DOI":"10.7326\/0003-4819-137-5_Part_1-200209030-00012","article-title":"Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force","volume":"137","author":"Humphrey","year":"2002","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.4065\/mcp.2010.0414_bib39","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1158\/1055-9965.EPI-07-2628","article-title":"Multiple diagnostic X-rays for spine deformities and risk of breast cancer","volume":"17","author":"Ronckers","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"10.4065\/mcp.2010.0414_bib40","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/djn440","article-title":"Estimated risk of radiation-induced breast cancer from mammographic screening for young BRCA mutation carriers","volume":"101","author":"Berrington de Gonzalez","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"15","key":"10.4065\/mcp.2010.0414_bib41","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1200\/JCO.2001.19.15.3524","article-title":"Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer","volume":"19","author":"Warner","year":"2001","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.4065\/mcp.2010.0414_bib42","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.292.11.1317","article-title":"Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination","volume":"292","author":"Warner","year":"2004","journal-title":"JAMA"},{"issue":"5","key":"10.4065\/mcp.2010.0414_bib43","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa031759","article-title":"Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition","volume":"351","author":"Kriege","year":"2004","journal-title":"N Engl J Med"},{"issue":"36","key":"10.4065\/mcp.2010.0414_bib44","doi-asserted-by":"crossref","first-page":"6124","DOI":"10.1200\/JCO.2009.24.4277","article-title":"Multimodality screening of high-risk women: a prospective cohort study","volume":"27","author":"Weinstein","year":"2009","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.4065\/mcp.2010.0414_bib45","doi-asserted-by":"crossref","first-page":"362","DOI":"10.7326\/0003-4819-143-5-200509060-00012","article-title":"Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force [published correction appears in Ann Intern Med. 2005;143(7):547]","volume":"143","author":"Nelson","year":"2005","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.4065\/mcp.2010.0414_bib46","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1002\/cncr.20221","article-title":"The development of interval breast malignancies in patients with BRCA mutations","volume":"100","author":"Komenaka","year":"2004","journal-title":"Cancer"},{"key":"10.4065\/mcp.2010.0414_bib47","author":"National Comprehensive Cancer Network"},{"issue":"3","key":"10.4065\/mcp.2010.0414_bib48","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1158\/1055-9965.EPI-07-2703","article-title":"A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group study","volume":"17","author":"Greene","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"20","key":"10.4065\/mcp.2010.0414_bib49","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1200\/JCO.2007.11.3449","article-title":"Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2","volume":"25","author":"Kauff","year":"2007","journal-title":"J Clin Oncol"},{"issue":"23","key":"10.4065\/mcp.2010.0414_bib50","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","article-title":"Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial [published correction appears in 2006;296(24):2926. JAMA. 2007;298(9):973]","volume":"295","author":"Vogel","year":"2006","journal-title":"JAMA"},{"issue":"10","key":"10.4065\/mcp.2010.0414_bib51","doi-asserted-by":"crossref","first-page":"703","DOI":"10.7326\/0000605-200911170-00147","article-title":"Systematic review: comparative effectiveness of medications to reduce risk for primary breast cancer","volume":"151","author":"Nelson","year":"2009","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.4065\/mcp.2010.0414_bib52","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1158\/1940-6207.CAPR-10-0076","article-title":"Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer","volume":"3","author":"Vogel","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"issue":"18","key":"10.4065\/mcp.2010.0414_bib53","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"90","author":"Fisher","year":"1998","journal-title":"J Natl Cancer Inst"},{"issue":"23","key":"10.4065\/mcp.2010.0414_bib54","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/jnci\/94.23.1773","article-title":"Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers","volume":"94","author":"Narod","year":"2002","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"10.4065\/mcp.2010.0414_bib55","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.6004\/jnccn.2009.0070","article-title":"NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis","volume":"7","author":"Bevers","year":"2009","journal-title":"J Natl Compr Canc Netw"},{"key":"10.4065\/mcp.2010.0414_bib56","series-title":"Hormone Receptors in Breast Cancer","first-page":"195","article-title":"Strategies of hormonal prevention","author":"Li","year":"2009"},{"issue":"3","key":"10.4065\/mcp.2010.0414_bib57","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/CEJ.0b013e328011ed98","article-title":"Translational approaches for the prevention of estrogen receptor-negative breast cancer","volume":"16","author":"Li","year":"2007","journal-title":"Eur J Cancer Prev"},{"issue":"1","key":"10.4065\/mcp.2010.0414_bib58","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/annonc\/mdg030","article-title":"Evidence-based management options for women at increased breast\/ovarian cancer risk","volume":"14","author":"Pichert","year":"2003","journal-title":"Ann Oncol"},{"issue":"7","key":"10.4065\/mcp.2010.0414_bib59","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJM199808133390702","article-title":"Oral contraceptives and the risk of hereditary ovarian cancer","volume":"339","author":"Narod","year":"1998","journal-title":"N Engl J Med"},{"issue":"2","key":"10.4065\/mcp.2010.0414_bib60","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1158\/1055-9965.EPI-04-0376","article-title":"Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutations","volume":"14","author":"Milne","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"10.4065\/mcp.2010.0414_bib61","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1158\/1055-9965.EPI-06-0258","article-title":"BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50","volume":"15","author":"Haile","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"10.4065\/mcp.2010.0414_bib62","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/jama.1995.03520300065039","article-title":"Ovarian cancer: screening, treatment, and follow-up","volume":"273","author":"NIH consensus conference","year":"1995","journal-title":"JAMA"},{"issue":"3","key":"10.4065\/mcp.2010.0414_bib63","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10897-007-9090-7","article-title":"Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors","volume":"16","author":"Berliner","year":"2007","journal-title":"J Genet Couns"},{"issue":"3","key":"10.4065\/mcp.2010.0414_bib64","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.amjsurg.2003.12.025","article-title":"Current comprehensive assessment and management of women at increased risk for breast cancer","volume":"187","author":"Hollingsworth","year":"2004","journal-title":"Am J Surg"},{"issue":"6","key":"10.4065\/mcp.2010.0414_bib65","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","article-title":"Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group","volume":"22","author":"Rebbeck","year":"2004","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.4065\/mcp.2010.0414_bib66","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"issue":"8","key":"10.4065\/mcp.2010.0414_bib67","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1200\/JCO.2007.13.9626","article-title":"Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study","volume":"26","author":"Kauff","year":"2008","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.4065\/mcp.2010.0414_bib68","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"10.4065\/mcp.2010.0414_bib69","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1200\/JCO.2002.10.101","article-title":"Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1\/2 mutations: an updated decision analysis","volume":"20","author":"Grann","year":"2002","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.4065\/mcp.2010.0414_bib70","doi-asserted-by":"crossref","first-page":"397","DOI":"10.7326\/0003-4819-144-6-200603210-00006","article-title":"Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation","volume":"144","author":"Anderson","year":"2006","journal-title":"Ann Intern Med"},{"issue":"22","key":"10.4065\/mcp.2010.0414_bib71","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1200\/JCO.2003.04.131","article-title":"Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations","volume":"21","author":"Levine","year":"2003","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.4065\/mcp.2010.0414_bib72","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/00000478-200110000-00009","article-title":"Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status","volume":"25","author":"Colgan","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.4065\/mcp.2010.0414_bib73","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.ajog.2004.04.028","article-title":"Surgical risk reduction: prophylactic salpingo-oophorectomy and prophylactic mastectomy","volume":"191","author":"Dowdy","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.4065\/mcp.2010.0414_bib74","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ygyno.2008.11.039","article-title":"A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer","volume":"112","author":"Fang","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"31","key":"10.4065\/mcp.2010.0414_bib75","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1200\/JCO.2004.00.8151","article-title":"Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group","volume":"23","author":"Rebbeck","year":"2005","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.4065\/mcp.2010.0414_bib76","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejca.2008.09.028","article-title":"Metabolic syndrome after risk-reducing salpingo-oophorectomy in women at high risk for hereditary breast ovarian cancer: a controlled observational study","volume":"45","author":"Michelsen","year":"2009","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.4065\/mcp.2010.0414_bib77","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1212\/01.wnl.0000276984.19542.e6","article-title":"Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause","volume":"69","author":"Rocca","year":"2007","journal-title":"Neurology"},{"issue":"19","key":"10.4065\/mcp.2010.0414_bib78","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/jnci\/djn313","article-title":"Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers","volume":"100","author":"Eisen","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"34","key":"10.4065\/mcp.2010.0414_bib79","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/jncimonographs\/lgi012","article-title":"Reproductive issues for women with BRCA mutations","volume":"2005","author":"Friedman","year":"2005","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"9267","key":"10.4065\/mcp.2010.0414_bib80","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(00)04642-0","article-title":"Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study","volume":"357","author":"Narod","year":"2001","journal-title":"Lancet"},{"issue":"2","key":"10.4065\/mcp.2010.0414_bib81","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1200\/JCO.2009.24.2057","article-title":"Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast\/ovarian cancer risks","volume":"28","author":"Oktay","year":"2010","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.4065\/mcp.2010.0414_bib82","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/jama.284.3.319","article-title":"Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy","volume":"284","author":"Frost","year":"2000","journal-title":"JAMA"},{"issue":"31","key":"10.4065\/mcp.2010.0414_bib83","doi-asserted-by":"crossref","first-page":"7849","DOI":"10.1200\/JCO.2005.09.233","article-title":"Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance","volume":"23","author":"Frost","year":"2005","journal-title":"J Clin Oncol"},{"issue":"24","key":"10.4065\/mcp.2010.0414_bib84","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1200\/JCO.2007.13.9568","article-title":"Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study","volume":"26","author":"Brandberg","year":"2008","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.4065\/mcp.2010.0414_bib85","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1200\/JCO.2009.22.7991","article-title":"Survival analysis of cancer risk reduction strategies for BRCA1\/2 mutation carriers","volume":"28","author":"Kurian","year":"2010","journal-title":"J Clin Oncol"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611603650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611603650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T14:15:49Z","timestamp":1675865749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611603650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":85,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0025619611603650"],"URL":"https:\/\/doi.org\/10.4065\/mcp.2010.0414","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4065\/mcp.2010.0414","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}